SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?
PRCT 30.93-3.1%Nov 10 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Douglas who wrote (157)5/7/1997 12:40:00 PM
From: Douglas   of 455
 
Annual Report was available as of 1 May 97 according to the Procept Investor Relations telephone recording. Procept will mail during the first two weeks of May.

Schwab shows the biotechnology group's near- to intermediate-term outlook as less than exciting as most of the good news has been priced into the stocks. For the pharmaceutical group the long-term rating is slightly underperform. Not a good time for Procept to seek additional funds.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext